{'fraction_non_alphanumeric': 0.025096525096525095, 'fraction_numerical': 0.011583011583011582, 'mean_word_length': 6.208333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A study of fatty acid binding protein 4 in HIV‐1 infection and in combination antiretroviral therapy‐related metabolic disturbances and lipodystrophy

The aim of the study was to determine circulating levels of fatty acid binding protein 4 (FABP‐4) in a cohort of HIV‐1‐infected patients treated with combination antiretroviral therapy (cART) and to investigate the relationships between FABP‐4 levels and insulin resistance, dyslipidaemia, lipodystrophy and levels of proinflammatory adipocytokines in these patients.